676 related articles for article (PubMed ID: 11297505)
1. Regulation of translation initiation by FRAP/mTOR.
Gingras AC; Raught B; Sonenberg N
Genes Dev; 2001 Apr; 15(7):807-26. PubMed ID: 11297505
[No Abstract] [Full Text] [Related]
2. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
Zhang D; Brodt P
Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
[TBL] [Abstract][Full Text] [Related]
3. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
4. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.
Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC
Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145
[TBL] [Abstract][Full Text] [Related]
5. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.
Neshat MS; Mellinghoff IK; Tran C; Stiles B; Thomas G; Petersen R; Frost P; Gibbons JJ; Wu H; Sawyers CL
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10314-9. PubMed ID: 11504908
[TBL] [Abstract][Full Text] [Related]
6. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B.
Lizcano JM; Alrubaie S; Kieloch A; Deak M; Leevers SJ; Alessi DR
Biochem J; 2003 Sep; 374(Pt 2):297-306. PubMed ID: 12841848
[TBL] [Abstract][Full Text] [Related]
7. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
Salh B; Wagey R; Marotta A; Tao JS; Pelech S
J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
[TBL] [Abstract][Full Text] [Related]
8. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
9. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
10. Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling.
Ott VL; Cambier JC
Semin Immunol; 2002 Feb; 14(1):1-6. PubMed ID: 11884225
[No Abstract] [Full Text] [Related]
11. Signaling from Akt to FRAP/TOR targets both 4E-BP and S6K in Drosophila melanogaster.
Miron M; Lasko P; Sonenberg N
Mol Cell Biol; 2003 Dec; 23(24):9117-26. PubMed ID: 14645523
[TBL] [Abstract][Full Text] [Related]
12. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids.
Shen WH; Boyle DW; Wisniowski P; Bade A; Liechty EA
J Endocrinol; 2005 May; 185(2):275-89. PubMed ID: 15845920
[TBL] [Abstract][Full Text] [Related]
13. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
14. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
[TBL] [Abstract][Full Text] [Related]
15. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
[TBL] [Abstract][Full Text] [Related]
16. Control of translation by the target of rapamycin proteins.
Gingras AC; Raught B; Sonenberg N
Prog Mol Subcell Biol; 2001; 27():143-74. PubMed ID: 11575159
[No Abstract] [Full Text] [Related]
17. Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI.
Raught B; Gingras AC; Gygi SP; Imataka H; Morino S; Gradi A; Aebersold R; Sonenberg N
EMBO J; 2000 Feb; 19(3):434-44. PubMed ID: 10654941
[TBL] [Abstract][Full Text] [Related]
18. Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin.
Oldham S; Montagne J; Radimerski T; Thomas G; Hafen E
Genes Dev; 2000 Nov; 14(21):2689-94. PubMed ID: 11069885
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin's resurrection: a new way to target the cancer cell cycle.
Garber K
J Natl Cancer Inst; 2001 Oct; 93(20):1517-9. PubMed ID: 11604470
[No Abstract] [Full Text] [Related]
20. Inhibition of cellular growth and proliferation by dTOR overexpression in Drosophila.
Hennig KM; Neufeld TP
Genesis; 2002; 34(1-2):107-10. PubMed ID: 12324961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
